{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T09:15:44Z","timestamp":1777540544776,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ijcard.2018.08.058","type":"journal-article","created":{"date-parts":[[2018,8,18]],"date-time":"2018-08-18T12:06:14Z","timestamp":1534593974000},"page":"153-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Clinical outcomes of \u0392-blocker therapy in cocaine-associated heart failure"],"prefix":"10.1016","volume":"277","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5879-4419","authenticated-orcid":false,"given":"Persio D.","family":"Lopez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4704-7784","authenticated-orcid":false,"given":"Adedoyin","family":"Akinlonu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuoyo O.","family":"Mene-Afejuku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6932-5477","authenticated-orcid":false,"given":"Carissa","family":"Dumancas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eder H.","family":"Cativo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferdinand","family":"Visco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savi","family":"Mushiyev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0857-6392","authenticated-orcid":false,"given":"Gerald","family":"Pekler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2018.08.058_bb0005","series-title":"Key Substance Use and Mental Health Indicators in the United States: Results from the 2015 National Survey on Drug Use and Health (HHS Publication No. SMA 16-4984, NSDUH Series H-51)","volume":"2016","author":"Center for Behavioral Health Statistics and Quality","year":"2016"},{"key":"10.1016\/j.ijcard.2018.08.058_bb0010","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1532-429X-16-26","article-title":"Long term effects of cocaine on the heart assessed by cardiovascular magnetic resonance at 3T","volume":"16","author":"Maceira","year":"2014","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"10.1016\/j.ijcard.2018.08.058_bb0015","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.amjcard.2008.06.045","article-title":"Illicit stimulant use in a United States heart failure population presenting to the emergency department (from the Acute Decompensated Heart Failure National Registry Emergency Module)","volume":"102","author":"Diercks","year":"2008","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2018.08.058_bb0020","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.tcm.2015.01.001","article-title":"Treating cocaine cardiotoxicity: does receptor subtype matter","volume":"25","author":"Long","year":"2015","journal-title":"Trends Cardiovasc. Med."},{"issue":"3","key":"10.1016\/j.ijcard.2018.08.058_bb0025","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1016\/j.ijcard.2013.03.187","article-title":"Beta blocker treatment of heart failure patients with ongoing cocaine use.[letter]","volume":"168","author":"Littmann","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2018.08.058_bb0030","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1016\/j.jacc.2013.01.014","volume":"61","author":"Anderson","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2018.08.058_bb0035","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1161\/CIRCULATIONAHA.107.188950","article-title":"Management of cocaine-associated chest pain and myocardial infarction: a scientific statement from the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology","volume":"117","author":"McCord","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.08.058_bb0040","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF03256574","article-title":"Cocaine cardiotoxicity: a review of the pathophysiology, pathology, and treatment options","volume":"9","author":"Phillips","year":"2009","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.ijcard.2018.08.058_bb0045","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/1074248416681644","article-title":"\u03b2-Blockers, cocaine, and the unopposed \u03b1-stimulation phenomenon","volume":"22","author":"Richards","year":"2017","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.ijcard.2018.08.058_bb0050","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00059-013-3976-y","article-title":"Successful treatment of cocaine-induced cardiotoxicity with carvedilol therapy","volume":"40","author":"\u00d6cal","year":"2015","journal-title":"Herz"},{"key":"10.1016\/j.ijcard.2018.08.058_bb0055","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/j.amjcard.2017.03.034","article-title":"Comparison of frequency of cardiovascular events and mortality in patients with heart failure using versus not using cocaine","volume":"119","author":"Nguyen","year":"2017","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2018.08.058_bb0060","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.tcm.2014.12.013","article-title":"Cardiovascular consequences of cocaine use","volume":"25","author":"Stankowski","year":"2015","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.ijcard.2018.08.058_bb0065","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s10741-014-9418-y","article-title":"Pathophysiological mechanisms of catecholamine and cocaine-mediated cardiotoxicity","volume":"19","author":"Liaudet","year":"2014","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.ijcard.2018.08.058_bb0070","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1136\/hrt.2011.226977","article-title":"Silent myocardial damage in cocaine addicts","volume":"97","author":"Aquaro","year":"2011","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.ijcard.2018.08.058_bb0075","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.ijcard.2014.03.141","article-title":"Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users.[letter]","volume":"173","author":"Aquaro","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2018.08.058_bb0080","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.amjcard.2013.11.023","article-title":"Characteristics, management, and outcomes of cocaine-positive patients with acute coronary syndrome (from the National Cardiovascular Data Registry)","volume":"113","author":"Gupta","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2018.08.058_bb0085","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"64","author":"Amsterdam","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2018.08.058_bb0090","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2018.08.058_bb0095","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2018.08.058_bb0100","doi-asserted-by":"crossref","first-page":"897","DOI":"10.7326\/0003-4819-112-12-897","article-title":"Potentiation of cocaine-induced coronary vasoconstriction by beta-adrenergic blockade","volume":"112","author":"Lange","year":"1990","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2018.08.058_bb0105","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/phar.1486","article-title":"Controversial therapeutics: the \u03b2-adrenergic antagonist and cocaine-associated cardiovascular complications dilemma","volume":"34","author":"Schurr","year":"2014","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijcard.2018.08.058_bb0110","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.annemergmed.2007.04.015","article-title":"Beta-blockers are associated with reduced risk of myocardial infarction after cocaine use","volume":"51","author":"Dattilo","year":"2008","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.ijcard.2018.08.058_bb0115","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/archinternmed.2010.115","article-title":"Beta-blockers for chest pain associated with recent cocaine use","volume":"170","author":"Rangel","year":"2010","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ijcard.2018.08.058_bb0120","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/1074248409358409","article-title":"Effects of labetalol on hemodynamic parameters and soluble biomarkers of inflammation in acute coronary syndrome in patients with active cocaine use","volume":"15","author":"Hoskins","year":"2010","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.ijcard.2018.08.058_bb0125","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.ijcard.2018.08.058_bb0130","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1097\/00005344-199219001-00014","article-title":"Receptor pharmacology of carvedilol in the human heart","volume":"19","author":"Bristow","year":"1992","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ijcard.2018.08.058_bb0135","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.3892\/mmr.2013.1329","article-title":"The effects of carvedilol on cardiac structural remodeling: the role of endogenous nitric oxide in the activity of carvedilol","volume":"7","author":"Chen","year":"2013","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ijcard.2018.08.058_bb0140","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ijcard.2010.08.018","article-title":"Carvedilol administration in acute myocardial infarction results in stronger inhibition of early markers of left ventricular remodeling than metoprolol","volume":"153","author":"Cimmino","year":"2011","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2018.08.058_bb0145","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1358\/dot.1998.34.11.487475","article-title":"Carvedilol: an effective antihypertensive drug with antiischemic\/antioxidant cardioprotective properties","volume":"34","author":"Rabasseda","year":"1998","journal-title":"Drugs Today (Barc.)"},{"issue":"1641","key":"10.1016\/j.ijcard.2018.08.058_bb0150","first-page":"1627","article-title":"Carvedilol: the new role of beta blockers in congestive heart failure","volume":"58","author":"Vanderhoff","year":"1998","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.ijcard.2018.08.058_bb0155","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/nm.2406","article-title":"Carvedilol and its new analogs suppress arrhythmogenic store overload-induced Ca2+ release","volume":"17","author":"Zhou","year":"2011","journal-title":"Nat. Med."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318325087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318325087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:40:17Z","timestamp":1759092017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527318325087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":31,"alternative-id":["S0167527318325087"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.08.058","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical outcomes of \u0392-blocker therapy in cocaine-associated heart failure","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.08.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}